FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109403008> ?p ?o ?g. }

• W2109403008 endingPage "541" @default.
• W2109403008 startingPage "531" @default.
• W2109403008 abstract "Mortality from non-Hodgkin’s lymphoma (NHL) is high, thus defining the need for additional therapeutic agents for this disease. Gallium nitrate is a metal compound that is presently approved for the treatment of hypercalcaemia associated with malignancy. In clinical trials first conducted over two decades ago, this drug was found to have antineoplastic activity in NHL. However, its development as an antineoplastic agent for the treatment of NHL was never rigorously pursued. Gallium has unique mechanisms of action that include its binding to transferrin in the circulation and targeting transferrin receptors present on lymphoma cells. As it shares chemical properties with iron, gallium can disrupt critical steps in iron homeostasis that are essential for tumour cell viability and growth and can inhibit the iron-dependent activity of ribonucleotide reductase. The drug may also target other cellular processes unrelated to iron. Phase I/II studies have shown that gallium nitrate displays the most efficacy and lowest toxicity in NHL when administered as a continuous intravenous infusion, producing response rates of 43% in patients with relapsed or refractory NHL. It does not suppress the white blood cells or platelets and does not share cross-resistance with other chemotherapeutic drugs. These characteristics make it particularly attractive for the treatment of myelosuppressed patients and for incorporation into combination therapy. Multi-institutional Phase II clinical trials are in progress to evaluate gallium nitrate as a single agent or in combination. These studies will help define its role in the current treatment of NHL." @default.
• W2109403008 created "2016-06-24" @default.
• W2109403008 creator A5075046330 @default.
• W2109403008 date "2004-05-01" @default.
• W2109403008 modified "2023-09-30" @default.
• W2109403008 title "Gallium nitrate for the treatment of non-Hodgkin’s lymphoma" @default.
• W2109403008 cites W1499737326 @default.
• W2109403008 cites W1515388283 @default.
• W2109403008 cites W1842269155 @default.
• W2109403008 cites W1848698181 @default.
• W2109403008 cites W191139234 @default.
• W2109403008 cites W1976770725 @default.
• W2109403008 cites W1977918201 @default.
• W2109403008 cites W1981325700 @default.
• W2109403008 cites W1985244701 @default.
• W2109403008 cites W2000591715 @default.
• W2109403008 cites W2004152308 @default.
• W2109403008 cites W2008060191 @default.
• W2109403008 cites W2037995060 @default.
• W2109403008 cites W2046785459 @default.
• W2109403008 cites W2050218059 @default.
• W2109403008 cites W2052275340 @default.
• W2109403008 cites W2057922530 @default.
• W2109403008 cites W2058849161 @default.
• W2109403008 cites W2059715782 @default.
• W2109403008 cites W2061520823 @default.
• W2109403008 cites W206701898 @default.
• W2109403008 cites W2069836511 @default.
• W2109403008 cites W2073325679 @default.
• W2109403008 cites W2074233516 @default.
• W2109403008 cites W2085796736 @default.
• W2109403008 cites W2094421559 @default.
• W2109403008 cites W2097422004 @default.
• W2109403008 cites W2109694492 @default.
• W2109403008 cites W2112877681 @default.
• W2109403008 cites W2118561871 @default.
• W2109403008 cites W2120078554 @default.
• W2109403008 cites W2152223492 @default.
• W2109403008 cites W2157732685 @default.
• W2109403008 cites W2178778111 @default.
• W2109403008 cites W2223245761 @default.
• W2109403008 cites W2316983914 @default.
• W2109403008 cites W2396170125 @default.
• W2109403008 cites W2419637041 @default.
• W2109403008 cites W276374572 @default.
• W2109403008 cites W4230866919 @default.
• W2109403008 cites W4251819674 @default.
• W2109403008 doi "https://doi.org/10.1517/13543784.13.5.531" @default.
• W2109403008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15155128" @default.
• W2109403008 hasPublicationYear "2004" @default.
• W2109403008 type Work @default.
• W2109403008 sameAs 2109403008 @default.
• W2109403008 citedByCount "55" @default.
• W2109403008 countsByYear W21094030082012 @default.
• W2109403008 countsByYear W21094030082013 @default.
• W2109403008 countsByYear W21094030082014 @default.
• W2109403008 countsByYear W21094030082015 @default.
• W2109403008 countsByYear W21094030082016 @default.
• W2109403008 countsByYear W21094030082017 @default.
• W2109403008 countsByYear W21094030082018 @default.
• W2109403008 countsByYear W21094030082019 @default.
• W2109403008 countsByYear W21094030082020 @default.
• W2109403008 countsByYear W21094030082021 @default.
• W2109403008 countsByYear W21094030082022 @default.
• W2109403008 countsByYear W21094030082023 @default.
• W2109403008 crossrefType "journal-article" @default.
• W2109403008 hasAuthorship W2109403008A5075046330 @default.
• W2109403008 hasConcept C104292427 @default.
• W2109403008 hasConcept C104317684 @default.
• W2109403008 hasConcept C126322002 @default.
• W2109403008 hasConcept C143998085 @default.
• W2109403008 hasConcept C178790620 @default.
• W2109403008 hasConcept C185592680 @default.
• W2109403008 hasConcept C203014093 @default.
• W2109403008 hasConcept C22814914 @default.
• W2109403008 hasConcept C2779338263 @default.
• W2109403008 hasConcept C4710235 @default.
• W2109403008 hasConcept C502942594 @default.
• W2109403008 hasConcept C550372918 @default.
• W2109403008 hasConcept C55493867 @default.
• W2109403008 hasConcept C71924100 @default.
• W2109403008 hasConcept C98274493 @default.
• W2109403008 hasConceptScore W2109403008C104292427 @default.
• W2109403008 hasConceptScore W2109403008C104317684 @default.
• W2109403008 hasConceptScore W2109403008C126322002 @default.
• W2109403008 hasConceptScore W2109403008C143998085 @default.
• W2109403008 hasConceptScore W2109403008C178790620 @default.
• W2109403008 hasConceptScore W2109403008C185592680 @default.
• W2109403008 hasConceptScore W2109403008C203014093 @default.
• W2109403008 hasConceptScore W2109403008C22814914 @default.
• W2109403008 hasConceptScore W2109403008C2779338263 @default.
• W2109403008 hasConceptScore W2109403008C4710235 @default.
• W2109403008 hasConceptScore W2109403008C502942594 @default.
• W2109403008 hasConceptScore W2109403008C550372918 @default.
• W2109403008 hasConceptScore W2109403008C55493867 @default.
• W2109403008 hasConceptScore W2109403008C71924100 @default.
• W2109403008 hasConceptScore W2109403008C98274493 @default.
• W2109403008 hasIssue "5" @default.

• next